Botox Statistics 2026

How many med spas offer Botox?

38,113 of the 53,215 US med spas in our directory (72%) offer Botox, going by their Google listings and websites.

Botox ranks 1st by provider count among the 81 treatments we track.

Med spas offering Botox are listed in 51 of the 51 states (counting Washington, DC).

Botox Provider Statistics: every number →

What else do Botox providers offer?

91% of med spas offering Botox also offer dermal fillers.

77% of med spas offering Botox also offer microneedling.

72% of med spas offering Botox also offer chemical peels.

Botox Provider Statistics: every number →

Who performs Botox?

56% of the 16,154 Botox providers that name their clinical team online list a physician (MD or DO).

43% of the 16,154 Botox providers that name their clinical team online list a nurse practitioner.

19% of the 16,154 Botox providers that name their clinical team online list a physician assistant.

Botox Provider Statistics: every number →

What do med spas charge for Botox?

1,561 of the 36,249 med spas offering Botox that have a website (4.3%) publish a price for it; most only quote prices at a consultation.

The median published price for Botox is $11 per unit, across 1,561 per-unit prices for Botox and the other neurotoxins (Dysport, Xeomin, Jeuveau, Daxxify).

The middle half of published Botox prices runs from $10 to $12 per unit.

Botox Price Statistics: every number →

What percentage of women get Botox?

Women accounted for 9,289,857 (94%) of the 9,883,711 neuromodulator procedures ASPS counted in 2024. [1]

Men accounted for 593,854 (6%) of US neuromodulator procedures in 2024 per ASPS, up 4.3% from 2023. [1]

Ages 40-54 accounted for 5,623,400 neuromodulator procedures in 2024 - 57% of the ASPS total, the largest age group by far. [1]

Botox Demographics Statistics: every number →

How many Botox procedures are done each year?

ASPS estimates 9,883,711 cosmetic neuromodulator injection procedures (Botox, Dysport, Xeomin, Jeuveau, Daxxify combined) were performed in the US in 2024, up 4% from 9,480,949 in 2023; this is the latest year ASPS published a count. [1]

ASPS's 2023 report counted 9,480,949 neuromodulator procedures in 2023, up 9% from 8,736,591 in 2022 - so the three-year ASPS series is 8.74 million (2022), 9.48 million (2023) and 9.88 million (2024). [2]

ASPS reported that neuromodulator injections among male patients rose 65% and dermal fillers among male patients rose 70% between 2019 and 2022. [4]

Botox Market Statistics: every number →

How common are Botox side effects (eyelid droop, headache, bruising)?

As of openFDA's July 30, 2026 update, FAERS held 39,057 adverse event reports naming Botox Cosmetic (2004-2026); 1,074 were coded serious, 283 involved hospitalization and 26 had death as an outcome - reports, not proven cases or rates. [8]

The most common FAERS terms in Botox Cosmetic reports are 'drug ineffective' (20,375 reports) and 'off label use' (5,819); among side effects, eyelid ptosis appears in 1,908 reports and headache in 1,456 (2026 data). [14]

FDA received 3,022 FAERS reports naming Botox Cosmetic in 2023, 1,565 in 2024 and 1,338 in 2025 (by FDA receipt date); yearly counts swing with manufacturer reporting practices, not just patient harm. [15]

Botox Safety Statistics: every number →

What is the success rate of Botox?

A 2021 Cochrane review of 65 randomized trials (14,919 participants) found onabotulinumtoxinA 20 units probably has a much higher patient-rated success rate than placebo for frown lines at week 4 (risk ratio 19.45; moderate-certainty evidence). [9]

Botox Results Statistics: every number →

How do patients rate Botox providers on Google?

Google reviews of med spas offering Botox average 4.84 stars, across 5,062,229 reviews of 35,370 rated listings.

94% of the Google reviews left for Botox providers are 5-star.

80% of Botox providers with at least 5 reviews hold a 4.8-star rating or better.

Botox Results Statistics: every number →

What published research says

These numbers come from outside sources, not our directory; each one links to its source below.

• Ages 55-69 accounted for 2,268,223 neuromodulator procedures (23%) in 2024 per ASPS. [1]
• Ages 30-39 accounted for 1,820,496 neuromodulator procedures (18%) in 2024 per ASPS. [1]
• Ages 20-29 accounted for only 142,907 neuromodulator procedures (1%) in ASPS's 2024 data, and ages 19 and under for 28,685 (0%). ASPS reported no neuromodulator figure for ages 70+. [1]
• ASPS's 2023 release said ages 40-54 accounted for over 56% of neuromodulator injections in 2023, while the 20-29 and 30-39 age groups each grew more than 8% and male neuromodulator patients grew 5%. [3]
• ASPS's 2023 fee table lists an average surgeon/physician fee of $435 for a neuromodulator injection in 2023, down from $528 in 2022. It is a per-treatment physician fee from plastic surgeons, not a med spa price and not a per-unit price. [5]
• AbbVie reported Botox Cosmetic worldwide net revenue of $2,602 million in 2025 (US $1,504 million; international $1,098 million), down 4.3% from $2,720 million in 2024 ($2,682 million in 2023). [6]
• AbbVie said US Botox Cosmetic net revenue fell 11% in 2025, 'primarily driven by unfavorable pricing due to customer loyalty program changes, lower market share and decreased consumer demand'. [6]
• In the first half of 2026, AbbVie reported Botox Cosmetic net revenue of $1,396 million worldwide (US $771 million, up 9.4% from $705 million; international $625 million), versus $1,248 million in the first half of 2025. [7]
• In a September 2025 Pew Research Center survey of 8,750 US adults, 5% said they had gotten nonsurgical cosmetic treatments such as Botox, dermal fillers or laser therapies to look younger, and 23% said they had or would consider them. [10]
• Evolus reported Jeuveau net revenue of $272.3 million in 2025, up from $264.3 million in 2024 and $199.7 million in 2023. [11]
• Evolus's 2025 10-K states there are only six approved injectable botulinum toxin type A neurotoxins in the US for aesthetic indications. [11]
• Galderma (maker of Dysport) reported worldwide Neuromodulator net sales of $1,259 million for the first nine months of 2026, up 16.9% at constant currency; it does not report Dysport alone or US-only figures in this release. [12]
• Revance reported Daxxify product revenue of $84.0 million in 2023 (its first full launch year), up from $11.0 million in 2022; the RHA filler collection brought in $128.6 million. [13]
• FAERS held 252 reports naming Letybo and 68 naming Daxxify (by reported product name) as of July 2026; none of the Letybo reports had a death outcome. [16]

What these numbers can't tell you

• Counts are Google Maps listings we classify as med spas, so they include dermatology and plastic surgery practices that offer med spa treatments and exclude spas without a Google listing.
• A treatment counts when the spa's Google listing or website names it, so a spa with an outdated menu can be over- or under-counted.
• Credentials count only clinicians a spa names with a credential (MD, DO, NP, PA, RN) on its own website, so spas that leave their team off their website are left out of those shares.
• Prices are published prices on med spa websites: we keep each spa's lowest posted price, which often is an introductory or member price, so the typical bill is higher.
• We hold no patient records: every figure describes providers, their listings and their Google reviews, not who gets treated.
• Ratings and review themes are Google's, as shown on each listing on the snapshot date; Google filters some reviews and does not publish how.

Medical disclaimer. MedSpaStandard is for education only and is not medical advice. Talk to a licensed provider about your own health, and check any provider's license with your state board.